We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-1.23%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$10.9B
AUM Growth
-$1.45B
Cap. Flow
-$1.12B
Cap. Flow %
-10.27%
Top 10 Hldgs %
18.76%
Holding
1,728
New
49
Increased
610
Reduced
957
Closed
98

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$10.5M
2
WELL icon
Welltower
WELL
+$6.31M
3
NOC icon
Northrop Grumman
NOC
+$5.71M
4
WFC icon
Wells Fargo
WFC
+$5.33M
5
ICE icon
Intercontinental Exchange
ICE
+$5.26M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$109M
2
AAPL icon
Apple
AAPL
+$95.9M
3
MSFT icon
Microsoft
MSFT
+$76.3M
4
AMZN icon
Amazon
AMZN
+$62.3M
5
AVGO icon
Broadcom
AVGO
+$53.8M

Sector Composition

Rank Sector Weight
1 Technology 24.36%
2 Healthcare 8.78%
3 Consumer Discretionary 8.24%
4 Financials 8.06%
5 Communication Services 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRT icon
976
Vertiv
VRT
$105B
$790K 0.01%
10,946
-144
-1% -$15.3K
PBA icon
977
Pembina Pipeline
PBA
$27.6B
$790K 0.01%
19,732
-5,323
-21% -$200K
GWRE icon
978
Guidewire Software
GWRE
$14.2B
$789K 0.01%
4,209
+2,805
+200% +$545K
TENB icon
979
Tenable Holdings
TENB
$4.01B
$788K 0.01%
22,541
-258
-1% -$10.1K
ETO
980
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
ETO
$520M
$786K 0.01%
31,989
-1,102
-3% -$28.1K
SMMT icon
981
Summit Therapeutics
SMMT
$11.1B
$784K 0.01%
40,657
-2,230
-5% -$44.7K
JRS icon
982
Nuveen Real Estate Income Fund
JRS
$246M
$783K 0.01%
95,031
+625
+0.7% +$5.31K
MUSA icon
983
Murphy USA
MUSA
$9.61B
$781K 0.01%
1,663
+228
+16% +$108K
PPC icon
984
Pilgrim's Pride
PPC
$6.54B
$779K 0.01%
14,297
-2,233
-14% -$112K
CET
985
Central Securities Corp
CET
$1.65B
$778K 0.01%
17,301
+29
+0.2% +$1.34K
NGG icon
986
National Grid
NGG
$81.3B
$778K 0.01%
12,374
-4,999
-29% -$294K
PHM icon
987
Pultegroup
PHM
$25.3B
$776K 0.01%
7,544
-1,988
-21% -$215K
RXRX icon
988
Recursion Pharmaceuticals
RXRX
$1.73B
$775K 0.01%
146,539
+3,482
+2% +$25.4K
BEAM icon
989
Beam Therapeutics
BEAM
$2.84B
$774K 0.01%
39,649
+3,822
+11% +$100K
APLS
990
DELISTED
Apellis Pharmaceuticals
APLS
$773K 0.01%
35,348
+2,741
+8% +$75.7K
EQNR icon
991
Equinor
EQNR
$92.4B
$773K 0.01%
29,209
+558
+2% +$13.5K
DAR icon
992
Darling Ingredients
DAR
$9.44B
$770K 0.01%
24,651
+2,873
+13% +$100K
CE icon
993
Celanese
CE
$4.82B
$765K 0.01%
13,477
-5,335
-28% -$333K
CRC icon
994
California Resources
CRC
$4.62B
$764K 0.01%
17,367
+4,185
+32% +$199K
WYNN icon
995
Wynn Resorts
WYNN
$10.6B
$763K 0.01%
9,140
-1,737
-16% -$148K
GRMN
996
Garmin
GRMN
$60B
$763K 0.01%
3,514
-1,011
-22% -$219K
HQH
997
abrdn Healthcare Investors
HQH
$1.32B
$762K 0.01%
46,902
+9,968
+27% +$171K
DNLI icon
998
Denali Therapeutics
DNLI
$3.97B
$762K 0.01%
56,012
+7,881
+16% +$151K
WTW icon
999
Willis Towers Watson
WTW
$32B
$761K 0.01%
2,251
-220
-9% -$71.7K
THQ
1000
abrdn Healthcare Opportunities Fund
THQ
$796M
$760K 0.01%
36,842
+66
+0.2% +$1.35K
38 39
40
41 42

Similar funds

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
ZIG
Zurich Insurance Group Zurich, Switzerland $12.7B AUM 53.57% 1-Year Est. Return

Guggenheim Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Guggenheim Capital held 1,728 positions worth $10.9B, down 12% from $12.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Guggenheim Capital withdrew a net $1.12B in Q1 2025, closing 98 positions and reducing 957 holdings. Its most notable exit was Insight Select Income Fund, an estimated $3.87M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Guggenheim Capital opened a new position in Hanover Insurance worth $1.41M.

  • Guggenheim Capital's largest Q1 2025 buy was Hanover Insurance: 8,133 shares worth $1.41M.
  • Guggenheim Capital added most to Merck in Q1 2025, an estimated $10.5M increase.
  • Guggenheim Capital's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $109M.
  • Guggenheim Capital fully exited Insight Select Income Fund in Q1 2025, selling an estimated $3.87M.
  • Guggenheim Capital's ten largest holdings make up 19% of its $10.9B portfolio in Q1 2025.
  • Guggenheim Capital opened 49 new positions and closed 98 in Q1 2025.
  • Guggenheim Capital's portfolio value fell 12% quarter-over-quarter to $10.9B.

Based on Guggenheim Capital's 13F filing for Q1 2025, filed 14 May 2025.